Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...

A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian cancer, highlighting that although most biomarkers show little heterogeneity, ...

Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form heterogeneous clones that fuel ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

This diversity, or heterogeneity, makes cancer harder to treat and can in turn lead to worse outcomes, especially in triple-negative breast cancer. Heterogeneity is a problem because currently we ...

This new resource aims to change that by providing a detailed framework for understanding how different cancers maintain ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...